Epidemiology and outcome of zygomycosis: A review of 929 reported cases

Maureen M. Roden, Theoklis E. Zaoutis, Wendy L. Buchanan, Tena A. Knudsen, Tatyana A. Sarkisova, Robert L. Schaufele, Michael Sein, Tin Sein, Christine C. Chiou, Jaclyn H. Chu, Dimitrios P. Kontoyiannis, Thomas J. Walsh

Research output: Contribution to journalArticle

Abstract

Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed 929 eligible cases. We included in the database only those cases for which the underlying condition, the pattern of infection, the surgical and antifungal treatments, and survival were described. Results. The mean age of patients was 38.8 years; 65% were male. The prevalence and overall mortality were 36% and 44%, respectively, for diabetes; 19% and 35%, respectively, for no underlying condition; and 17% and 66%, respectively, for malignancy. The most common types of infection were sinus (39%), pulmonary (24%), and cutaneous (19%). Dissemination developed in 23% of cases. Mortality varied with the site of infection: 96% of patients with disseminated disease died, 85% with gastrointestinal infection died, and 76% with pulmonary infection died. The majority of patients with malignancy (92 [60%] of 154) had pulmonary disease, whereas the majority of patients with diabetes (222 [66%] of 337) had sinus disease. Rhinocerebral disease was seen more frequently in patients with diabetes (145 [33%] of 337), compared with patients with malignancy (6 [4%] of 154). Hematogenous dissemination to skin was rare; however, 78 (44%) of 176 cutaneous infections were complicated by deep extension or dissemination. Survival was 3% (8 of 241 patients) for cases that were not treated, 61% (324 of 532) for cases treated with amphotericin B deoxycholate, 57% (51 of 90) for cases treated with surgery alone, and 70% (328 of 470) for cases treated with antifungal therapy and surgery. By multivariate analysis, infection due to Cunninghamella species and disseminated disease were independently associated with increased rates of death (odds ratios, 2.78 and 11.2, respectively). Conclusions. Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy.

Original languageEnglish (US)
Pages (from-to)634-653
Number of pages20
JournalClinical Infectious Diseases
Volume41
Issue number5
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Zygomycosis
Epidemiology
Infection
Skin
Mortality
Cunninghamella
Neoplasms
Lung
Survival
Lung Diseases
Language
Therapeutics
Multivariate Analysis
Odds Ratio
Databases

ASJC Scopus subject areas

  • Immunology

Cite this

Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., ... Walsh, T. J. (2005). Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clinical Infectious Diseases, 41(5), 634-653. https://doi.org/10.1086/432579

Epidemiology and outcome of zygomycosis : A review of 929 reported cases. / Roden, Maureen M.; Zaoutis, Theoklis E.; Buchanan, Wendy L.; Knudsen, Tena A.; Sarkisova, Tatyana A.; Schaufele, Robert L.; Sein, Michael; Sein, Tin; Chiou, Christine C.; Chu, Jaclyn H.; Kontoyiannis, Dimitrios P.; Walsh, Thomas J.

In: Clinical Infectious Diseases, Vol. 41, No. 5, 01.09.2005, p. 634-653.

Research output: Contribution to journalArticle

Roden, MM, Zaoutis, TE, Buchanan, WL, Knudsen, TA, Sarkisova, TA, Schaufele, RL, Sein, M, Sein, T, Chiou, CC, Chu, JH, Kontoyiannis, DP & Walsh, TJ 2005, 'Epidemiology and outcome of zygomycosis: A review of 929 reported cases', Clinical Infectious Diseases, vol. 41, no. 5, pp. 634-653. https://doi.org/10.1086/432579
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clinical Infectious Diseases. 2005 Sep 1;41(5):634-653. https://doi.org/10.1086/432579
Roden, Maureen M. ; Zaoutis, Theoklis E. ; Buchanan, Wendy L. ; Knudsen, Tena A. ; Sarkisova, Tatyana A. ; Schaufele, Robert L. ; Sein, Michael ; Sein, Tin ; Chiou, Christine C. ; Chu, Jaclyn H. ; Kontoyiannis, Dimitrios P. ; Walsh, Thomas J. / Epidemiology and outcome of zygomycosis : A review of 929 reported cases. In: Clinical Infectious Diseases. 2005 ; Vol. 41, No. 5. pp. 634-653.
@article{8a7bfb61f8d042dc8de4721a359620d4,
title = "Epidemiology and outcome of zygomycosis: A review of 929 reported cases",
abstract = "Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed 929 eligible cases. We included in the database only those cases for which the underlying condition, the pattern of infection, the surgical and antifungal treatments, and survival were described. Results. The mean age of patients was 38.8 years; 65{\%} were male. The prevalence and overall mortality were 36{\%} and 44{\%}, respectively, for diabetes; 19{\%} and 35{\%}, respectively, for no underlying condition; and 17{\%} and 66{\%}, respectively, for malignancy. The most common types of infection were sinus (39{\%}), pulmonary (24{\%}), and cutaneous (19{\%}). Dissemination developed in 23{\%} of cases. Mortality varied with the site of infection: 96{\%} of patients with disseminated disease died, 85{\%} with gastrointestinal infection died, and 76{\%} with pulmonary infection died. The majority of patients with malignancy (92 [60{\%}] of 154) had pulmonary disease, whereas the majority of patients with diabetes (222 [66{\%}] of 337) had sinus disease. Rhinocerebral disease was seen more frequently in patients with diabetes (145 [33{\%}] of 337), compared with patients with malignancy (6 [4{\%}] of 154). Hematogenous dissemination to skin was rare; however, 78 (44{\%}) of 176 cutaneous infections were complicated by deep extension or dissemination. Survival was 3{\%} (8 of 241 patients) for cases that were not treated, 61{\%} (324 of 532) for cases treated with amphotericin B deoxycholate, 57{\%} (51 of 90) for cases treated with surgery alone, and 70{\%} (328 of 470) for cases treated with antifungal therapy and surgery. By multivariate analysis, infection due to Cunninghamella species and disseminated disease were independently associated with increased rates of death (odds ratios, 2.78 and 11.2, respectively). Conclusions. Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy.",
author = "Roden, {Maureen M.} and Zaoutis, {Theoklis E.} and Buchanan, {Wendy L.} and Knudsen, {Tena A.} and Sarkisova, {Tatyana A.} and Schaufele, {Robert L.} and Michael Sein and Tin Sein and Chiou, {Christine C.} and Chu, {Jaclyn H.} and Kontoyiannis, {Dimitrios P.} and Walsh, {Thomas J.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1086/432579",
language = "English (US)",
volume = "41",
pages = "634--653",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Epidemiology and outcome of zygomycosis

T2 - A review of 929 reported cases

AU - Roden, Maureen M.

AU - Zaoutis, Theoklis E.

AU - Buchanan, Wendy L.

AU - Knudsen, Tena A.

AU - Sarkisova, Tatyana A.

AU - Schaufele, Robert L.

AU - Sein, Michael

AU - Sein, Tin

AU - Chiou, Christine C.

AU - Chu, Jaclyn H.

AU - Kontoyiannis, Dimitrios P.

AU - Walsh, Thomas J.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed 929 eligible cases. We included in the database only those cases for which the underlying condition, the pattern of infection, the surgical and antifungal treatments, and survival were described. Results. The mean age of patients was 38.8 years; 65% were male. The prevalence and overall mortality were 36% and 44%, respectively, for diabetes; 19% and 35%, respectively, for no underlying condition; and 17% and 66%, respectively, for malignancy. The most common types of infection were sinus (39%), pulmonary (24%), and cutaneous (19%). Dissemination developed in 23% of cases. Mortality varied with the site of infection: 96% of patients with disseminated disease died, 85% with gastrointestinal infection died, and 76% with pulmonary infection died. The majority of patients with malignancy (92 [60%] of 154) had pulmonary disease, whereas the majority of patients with diabetes (222 [66%] of 337) had sinus disease. Rhinocerebral disease was seen more frequently in patients with diabetes (145 [33%] of 337), compared with patients with malignancy (6 [4%] of 154). Hematogenous dissemination to skin was rare; however, 78 (44%) of 176 cutaneous infections were complicated by deep extension or dissemination. Survival was 3% (8 of 241 patients) for cases that were not treated, 61% (324 of 532) for cases treated with amphotericin B deoxycholate, 57% (51 of 90) for cases treated with surgery alone, and 70% (328 of 470) for cases treated with antifungal therapy and surgery. By multivariate analysis, infection due to Cunninghamella species and disseminated disease were independently associated with increased rates of death (odds ratios, 2.78 and 11.2, respectively). Conclusions. Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy.

AB - Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed 929 eligible cases. We included in the database only those cases for which the underlying condition, the pattern of infection, the surgical and antifungal treatments, and survival were described. Results. The mean age of patients was 38.8 years; 65% were male. The prevalence and overall mortality were 36% and 44%, respectively, for diabetes; 19% and 35%, respectively, for no underlying condition; and 17% and 66%, respectively, for malignancy. The most common types of infection were sinus (39%), pulmonary (24%), and cutaneous (19%). Dissemination developed in 23% of cases. Mortality varied with the site of infection: 96% of patients with disseminated disease died, 85% with gastrointestinal infection died, and 76% with pulmonary infection died. The majority of patients with malignancy (92 [60%] of 154) had pulmonary disease, whereas the majority of patients with diabetes (222 [66%] of 337) had sinus disease. Rhinocerebral disease was seen more frequently in patients with diabetes (145 [33%] of 337), compared with patients with malignancy (6 [4%] of 154). Hematogenous dissemination to skin was rare; however, 78 (44%) of 176 cutaneous infections were complicated by deep extension or dissemination. Survival was 3% (8 of 241 patients) for cases that were not treated, 61% (324 of 532) for cases treated with amphotericin B deoxycholate, 57% (51 of 90) for cases treated with surgery alone, and 70% (328 of 470) for cases treated with antifungal therapy and surgery. By multivariate analysis, infection due to Cunninghamella species and disseminated disease were independently associated with increased rates of death (odds ratios, 2.78 and 11.2, respectively). Conclusions. Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy.

UR - http://www.scopus.com/inward/record.url?scp=23844464106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844464106&partnerID=8YFLogxK

U2 - 10.1086/432579

DO - 10.1086/432579

M3 - Article

C2 - 16080086

AN - SCOPUS:23844464106

VL - 41

SP - 634

EP - 653

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -